Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Radiotherapy Gives Long-Term Disease Control in Prostate CancerLong-term outcomes in prostate cancer trials continue to support radiation therapy as a standard of care that provides excellent
local control and minimal late toxicity over many years to come.
SABR: Strong Contender for Treating Solitary Kidney CancerStereotactic ablative radiotherapy (SABR) provides good local control and causes minimal kidney damage in patients for whom
preservation of kidney function is of paramount importance.
